Stock Track | Myriad Genetics Soars 5.03% as Wells Fargo Raises Target Price

Stock Track11-05

Shares of Myriad Genetics (MYGN) are soaring 5.03% in intraday trading on Wednesday, showcasing significant investor enthusiasm for the genetic testing company. The stock's upward movement comes amid positive analyst sentiment, driving renewed interest in MYGN.

The catalyst for today's stock surge appears to be Wells Fargo's decision to raise its target price for Myriad Genetics. The financial services company has increased its price target from $6 to $6.5, signaling increased confidence in MYGN's future performance and growth prospects.

This upward revision in the target price by a major financial institution like Wells Fargo could be interpreted as a vote of confidence in Myriad Genetics' business model and future outlook. Investors often react positively to such analyst upgrades, as they can indicate potential undervaluation or improved business prospects. As the market digests this new information, it will be interesting to see if MYGN can maintain its momentum in the coming trading sessions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1138725436?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-05 23:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1138725436","market":"nz","top_or_hot":-1,"title":"Stock Track | Myriad Genetics Soars 5.03% as Wells Fargo Raises Target Price","media":"Stock Track","content":"<p>Shares of Myriad Genetics (MYGN) are soaring 5.03% in intraday trading on Wednesday, showcasing significant investor enthusiasm for the genetic testing company. The stock's upward movement comes amid positive analyst sentiment, driving renewed interest in MYGN.</p>\n\n<p>The catalyst for today's stock surge appears to be Wells Fargo's decision to raise its target price for Myriad Genetics. The financial services company has increased its price target from $6 to $6.5, signaling increased confidence in MYGN's future performance and growth prospects.</p>\n\n<p>This upward revision in the target price by a major financial institution like Wells Fargo could be interpreted as a vote of confidence in Myriad Genetics' business model and future outlook. Investors often react positively to such analyst upgrades, as they can indicate potential undervaluation or improved business prospects. As the market digests this new information, it will be interesting to see if MYGN can maintain its momentum in the coming trading sessions.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Myriad Genetics Soars 5.03% as Wells Fargo Raises Target Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Myriad Genetics Soars 5.03% as Wells Fargo Raises Target Price\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-05 23:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Myriad Genetics (MYGN) are soaring 5.03% in intraday trading on Wednesday, showcasing significant investor enthusiasm for the genetic testing company. The stock's upward movement comes amid positive analyst sentiment, driving renewed interest in MYGN.</p>\n\n<p>The catalyst for today's stock surge appears to be Wells Fargo's decision to raise its target price for Myriad Genetics. The financial services company has increased its price target from $6 to $6.5, signaling increased confidence in MYGN's future performance and growth prospects.</p>\n\n<p>This upward revision in the target price by a major financial institution like Wells Fargo could be interpreted as a vote of confidence in Myriad Genetics' business model and future outlook. Investors often react positively to such analyst upgrades, as they can indicate potential undervaluation or improved business prospects. As the market digests this new information, it will be interesting to see if MYGN can maintain its momentum in the coming trading sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MYGN","symbol_name":"万基遗传","start_time":0,"source_url":"","article_id":"1138725436","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1138725436","pubTimestamp":1762358068,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Myriad Genetics (MYGN) are soaring 5.03% in intraday trading on Wednesday, showcasing significant investor enthusiasm for the genetic testing company. The stock's upward movement comes amid...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MYGN":"万基遗传"},"translate_title":"个股追踪|富国银行上调目标价Myriad Genetics大涨5.03%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MYGN":1},"content_text":"Shares of Myriad Genetics (MYGN) are soaring 5.03% in intraday trading on Wednesday, showcasing significant investor enthusiasm for the genetic testing company. The stock's upward movement comes amid positive analyst sentiment, driving renewed interest in MYGN.\nThe catalyst for today's stock surge appears to be Wells Fargo's decision to raise its target price for Myriad Genetics. The financial services company has increased its price target from $6 to $6.5, signaling increased confidence in MYGN's future performance and growth prospects.\nThis upward revision in the target price by a major financial institution like Wells Fargo could be interpreted as a vote of confidence in Myriad Genetics' business model and future outlook. Investors often react positively to such analyst upgrades, as they can indicate potential undervaluation or improved business prospects. As the market digests this new information, it will be interesting to see if MYGN can maintain its momentum in the coming trading sessions.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1138725436","isCrawlerRequest":true}